• Homepage
  • About
    • Technical Information
    • Management Team
    • Contact Us
  • News
    • Recent News
    • Journal Articles
  • Resources
    • Patient Resources
      • Ovarian Cancer
      • Ovarian Cancer Symptoms
      • Ovarian Cancer Statistics
      • Prostate Cancer
      • Prostate Cancer Symptoms
      • Prostate Cancer Statistics
    • Physician Resources
      • Why Hepsin
      • Clinical Data
      • Getting Tested
      • Beyond CA125/PSA
  • Contact Us

Type II transmembrane serine proteases as potential targets for cancer therapy

Expression and prognostic value of matriptase in ovarian serous adenocarcinoma.

High Hepsin expression predicts poor prognosis in Gastric Cancer

Archives

  • March 2018
  • October 2017
  • May 2017

Categories

  • Journal Articles
  • Press Releases
  • Recent News

Links

  • Investors
  • Contact Us

SITE SEARCH

GET SOCIAL

IN THE NEWS

Baptist Health to Start Offering New Hepsin Test
Baptist Health Enters Agreement with Stage I
  • Copyright © 2017 Stage I Diagnostics, Inc. All Rights Reserved
  • Privacy Policy
  • Terms of Use
  • Sitemap

website by: ZGN Creative

  • Homepage
  • About
    ▼
    • Technical Information
    • Management Team
    • Contact Us
  • News
    ▼
    • Recent News
    • Journal Articles
  • Resources
    ▼
    • Patient Resources
      ▼
      • Ovarian Cancer
      • Ovarian Cancer Symptoms
      • Ovarian Cancer Statistics
      • Prostate Cancer
      • Prostate Cancer Symptoms
      • Prostate Cancer Statistics
    • Physician Resources
      ▼
      • Why Hepsin
      • Clinical Data
      • Getting Tested
      • Beyond CA125/PSA
  • Contact Us